Cardiovascular risk burden, dementia risk and brain structural imaging markers: a study from UK Biobank

Yaying Cao1,2, Gaohong Zhu3, Chengwu Feng2

  • 1Department of Food Nutrition and Health, School of Medicine and Health, Harbin Institute of Technology, Harbin, Heilongjiang, China.

General Psychiatry
|January 31, 2024
PubMed

Insights

High cardiovascular risk burden increases dementia risk, including Alzheimer's and vascular dementia, largely independent of genetics. This highlights the importance of managing heart health for brain health.

Area of Science:

  • Neuroscience
  • Cardiology
  • Gerontology

Background:

  • Cardiovascular risk burden is linked to dementia risk and brain structure changes.
  • The independent roles of genetics and incident cardiovascular disease (CVD) in this association require further investigation.

Purpose of the Study:

  • To assess the association between overall cardiovascular risk burden and the risk of major dementia subtypes.
  • To explore the influence of genetics and incident CVD on this relationship.
  • To examine the impact of cardiovascular risk on brain structure volumes.

Main Methods:

  • A prospective UK Biobank study of 354,654 participants (mean age 56.4) free of CVD and dementia.
  • Cardiovascular risk assessed using the Framingham General Cardiovascular Risk Score (FGCRS).
  • Brain MRI data analyzed for 15,104 participants; dementia cases identified via inpatient and death registers.

Main Results:

  • Higher FGCRS correlated with increased all-cause, Alzheimer's, and vascular dementia risk, independent of lifestyle, clinical factors, and polygenic risk score (PRS).
  • Incident stroke and coronary heart disease explained 14% of the FGCRS-dementia association.
  • Higher FGCRS linked to increased white matter hyperintensities and reduced grey/cortical volumes.

Conclusions:

  • Cardiovascular risk burden is associated with major dementia subtypes, independent of CVD onset and genetic predisposition.
  • Managing cardiovascular risk factors is crucial for mitigating dementia risk.
  • Findings emphasize the link between cardiovascular health and brain structure integrity.
Abstract

Related Concept Videos

Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
163
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
92
Brain Imaging01:14

Brain Imaging

Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
232
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
158
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.4K